{
  "DOI": "10.1007/s10689-011-9484-4",
  "ISSN": [
    "1389-9600",
    "1573-7292"
  ],
  "URL": "http://dx.doi.org/10.1007/s10689-011-9484-4",
  "alternative-id": [
    "9484"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Pujol",
      "given": "Pascal",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "name": "On behalf the French Federation of Cancer Centres (FNCLCC)",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Lasset",
      "given": "Christine",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Berthet",
      "given": "Pascaline",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Dugast",
      "given": "Catherine",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Delaloge",
      "given": "Suzette",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Fricker",
      "given": "Jean-Pierre",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Tennevet",
      "given": "Isabelle",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Chabbert-Buffet",
      "given": "Nathalie",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "This",
      "given": "Pascale",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Baudry",
      "given": "Karen",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Lemonnier",
      "given": "Jerome",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Roca",
      "given": "Lise",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Mijonnet",
      "given": "Sylvie",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Gesta",
      "given": "Paul",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Chiesa",
      "given": "Jean",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Dreyfus",
      "given": "Helene",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Vennin",
      "given": "Philippe",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Delnatte",
      "given": "Capucine",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Bignon",
      "given": "Yves Jean",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Lortholary",
      "given": "Alain",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Prieur",
      "given": "Fabienne",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Gladieff",
      "given": "Laurence",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Lesur",
      "given": "Anne",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Clough",
      "given": "Krishna B.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Nogues",
      "given": "Catherine",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Martin",
      "given": "Anne-Laure",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Familial Cancer"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": []
  },
  "created": {
    "date-parts": [
      [
        2011,
        11,
        10
      ]
    ],
    "date-time": "2011-11-10T10:47:49Z",
    "timestamp": 1320922069000
  },
  "deposited": {
    "date-parts": [
      [
        2019,
        6,
        19
      ]
    ],
    "date-time": "2019-06-19T10:45:46Z",
    "timestamp": 1560941146000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        5,
        2
      ]
    ],
    "date-time": "2024-05-02T14:59:49Z",
    "timestamp": 1714661989695
  },
  "is-referenced-by-count": 22,
  "issn-type": [
    {
      "type": "print",
      "value": "1389-9600"
    },
    {
      "type": "electronic",
      "value": "1573-7292"
    }
  ],
  "issue": "1",
  "issued": {
    "date-parts": [
      [
        2011,
        11,
        11
      ]
    ]
  },
  "journal-issue": {
    "issue": "1",
    "published-print": {
      "date-parts": [
        [
          2012,
          3
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2011,
            11,
            11
          ]
        ],
        "date-time": "2011-11-11T00:00:00Z",
        "timestamp": 1320969600000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-011-9484-4.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1007/s10689-011-9484-4/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-011-9484-4",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "77-84",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2011,
        11,
        11
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2011,
        11,
        11
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2012,
        3
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1086/375033",
      "author": "A Antoniou",
      "doi-asserted-by": "crossref",
      "first-page": "1117",
      "issue": "5",
      "journal-title": "Am J Hum Genet",
      "key": "9484_CR1",
      "unstructured": "Antoniou A et al (2003) Average risks of breast and ovarian cancer associated with BRCA1/2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72(5):1117–1130",
      "volume": "72",
      "year": "2003"
    },
    {
      "DOI": "10.1056/NEJMcp071286",
      "author": "M Robson",
      "doi-asserted-by": "crossref",
      "first-page": "154",
      "issue": "2",
      "journal-title": "N Engl J Med",
      "key": "9484_CR2",
      "unstructured": "Robson M, Offit K (2007) Clinical practice. Management of an inherited predisposition to breast cancer. N Engl J Med 357(2):154–162",
      "volume": "357",
      "year": "2007"
    },
    {
      "DOI": "10.1126/science.1088759",
      "author": "MC King",
      "doi-asserted-by": "crossref",
      "first-page": "643",
      "issue": "5645",
      "journal-title": "Science",
      "key": "9484_CR3",
      "unstructured": "King MC, Marks JH, Mandell JB (2003) Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302(5645):643–646",
      "volume": "302",
      "year": "2003"
    },
    {
      "DOI": "10.1200/JCO.2004.04.188",
      "author": "TR Rebbeck",
      "doi-asserted-by": "crossref",
      "first-page": "1055",
      "issue": "6",
      "journal-title": "J Clin Oncol",
      "key": "9484_CR4",
      "unstructured": "Rebbeck TR et al (2004) Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE study group. J Clin Oncol 22(6):1055–1062",
      "volume": "22",
      "year": "2004"
    },
    {
      "key": "9484_CR5",
      "unstructured": "Klijn JEA (2004) Results of the extended series on prophylactic mastectomy versus surveillance in BRCA1/2 mutation carriers in Rotterdam. Breast Cancer Res Treat 88(Suppl 1):10"
    },
    {
      "DOI": "10.1056/NEJM200107193450301",
      "author": "H Meijers-Heijboer",
      "doi-asserted-by": "crossref",
      "first-page": "159",
      "issue": "3",
      "journal-title": "N Engl J Med",
      "key": "9484_CR6",
      "unstructured": "Meijers-Heijboer H et al (2001) Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1/2 mutation. N Engl J Med 345(3):159–164",
      "volume": "345",
      "year": "2001"
    },
    {
      "DOI": "10.1016/S1470-2045(05)70210-2",
      "author": "KA Metcalfe",
      "doi-asserted-by": "crossref",
      "first-page": "431",
      "issue": "6",
      "journal-title": "Lancet Oncol",
      "key": "9484_CR7",
      "unstructured": "Metcalfe KA, Semple JL, Narod SA (2005) Time to reconsider subcutaneous mastectomy for breast-cancer prevention. Lancet Oncol 6(6):431–434",
      "volume": "6",
      "year": "2005"
    },
    {
      "DOI": "10.1016/j.breast.2010.05.003",
      "author": "J Gahm",
      "doi-asserted-by": "crossref",
      "first-page": "462",
      "issue": "6",
      "journal-title": "Breast",
      "key": "9484_CR8",
      "unstructured": "Gahm J, Wickman M, Brandberg Y (2010) Bilateral prophylactic mastectomy in women with inherited risk of breast cancer: prevalence of pain and discomfort, impact on sexuality, quality of life and feelings of regret 2 years after surgery. Breast 19(6):462–469",
      "volume": "19",
      "year": "2010"
    },
    {
      "DOI": "10.1200/JCO.2007.13.9568",
      "author": "Y Brandberg",
      "doi-asserted-by": "crossref",
      "first-page": "3943",
      "issue": "24",
      "journal-title": "J Clin Oncol",
      "key": "9484_CR9",
      "unstructured": "Brandberg Y et al (2008) Psychological reactions, quality of life, and body image after bilateral prophylactic mastectomy in women at high risk for breast cancer: a prospective 1-year follow-up study. J Clin Oncol 26(24):3943–3949",
      "volume": "26",
      "year": "2008"
    },
    {
      "DOI": "10.1002/ijc.23340",
      "author": "KA Metcalfe",
      "doi-asserted-by": "crossref",
      "first-page": "2017",
      "issue": "9",
      "journal-title": "Int J Cancer",
      "key": "9484_CR10",
      "unstructured": "Metcalfe KA et al (2008) International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers. Int J Cancer 122(9):2017–2022",
      "volume": "122",
      "year": "2008"
    },
    {
      "DOI": "10.1200/JCO.2009.27.6774",
      "author": "EB Habermann",
      "doi-asserted-by": "crossref",
      "first-page": "3437",
      "issue": "21",
      "journal-title": "J Clin Oncol",
      "key": "9484_CR11",
      "unstructured": "Habermann EB et al (2010) Are mastectomy rates really increasing in the United States? J Clin Oncol 28(21):3437–3441",
      "volume": "28",
      "year": "2010"
    },
    {
      "DOI": "10.1007/s11912-009-0070-y",
      "author": "TM Tuttle",
      "doi-asserted-by": "crossref",
      "first-page": "16",
      "issue": "1",
      "journal-title": "Curr Oncol Rep",
      "key": "9484_CR12",
      "unstructured": "Tuttle TM et al (2010) The increasing use of prophylactic mastectomy in the prevention of breast cancer. Curr Oncol Rep 12(1):16–21",
      "volume": "12",
      "year": "2010"
    },
    {
      "DOI": "10.1002/cncr.24623",
      "author": "CC McLaughlin",
      "doi-asserted-by": "crossref",
      "first-page": "5404",
      "issue": "23",
      "journal-title": "Cancer",
      "key": "9484_CR13",
      "unstructured": "McLaughlin CC, Lillquist PP, Edge SB (2005) Surveillance of prophylactic mastectomy: trends in use from 1995 to 2005. Cancer 115(23):5404–5412",
      "volume": "115",
      "year": "2005"
    },
    {
      "DOI": "10.1016/S0960-9776(09)70282-6",
      "author": "WC Wood",
      "doi-asserted-by": "crossref",
      "first-page": "S93",
      "issue": "Suppl 3",
      "journal-title": "Breast",
      "key": "9484_CR14",
      "unstructured": "Wood WC (2009) Should the use of contralateral prophylactic mastectomy be increasing as it is? Breast 18(Suppl 3):S93–S95",
      "volume": "18",
      "year": "2009"
    },
    {
      "DOI": "10.1001/jama.286.18.2251",
      "author": "MC King",
      "doi-asserted-by": "crossref",
      "first-page": "2251",
      "issue": "18",
      "journal-title": "JAMA",
      "key": "9484_CR15",
      "unstructured": "King MC et al (2001) Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: national surgical adjuvant breast and bowel project (NSABP-P1) breast cancer prevention trial. JAMA 286(18):2251–2256",
      "volume": "286",
      "year": "2001"
    },
    {
      "DOI": "10.2217/17455057.5.1.63",
      "author": "KA Metcalfe",
      "doi-asserted-by": "crossref",
      "first-page": "63",
      "issue": "1",
      "journal-title": "Womens Health (Lond Engl)",
      "key": "9484_CR16",
      "unstructured": "Metcalfe KA (2009) Oophorectomy for breast cancer prevention in women with BRCA1/2 mutations. Womens Health (Lond Engl) 5(1):63–68",
      "volume": "5",
      "year": "2009"
    },
    {
      "DOI": "10.1097/GCO.0b013e32801195da",
      "author": "SM Domchek",
      "doi-asserted-by": "crossref",
      "first-page": "27",
      "issue": "1",
      "journal-title": "Curr Opin Obstet Gynecol",
      "key": "9484_CR17",
      "unstructured": "Domchek SM, Rebbeck TR (2007) Prophylactic oophorectomy in women at increased cancer risk. Curr Opin Obstet Gynecol 19(1):27–30",
      "volume": "19",
      "year": "2007"
    },
    {
      "DOI": "10.1200/JCO.2007.11.3449",
      "author": "ND Kauff",
      "doi-asserted-by": "crossref",
      "first-page": "2921",
      "issue": "20",
      "journal-title": "J Clin Oncol",
      "key": "9484_CR18",
      "unstructured": "Kauff ND, Barakat RR (2007) Risk-reducing salpingo-oophorectomy in patients with germline mutations in BRCA1/2. J Clin Oncol 25(20):2921–2927",
      "volume": "25",
      "year": "2007"
    },
    {
      "DOI": "10.1002/cncr.21367",
      "author": "M Noruzinia",
      "doi-asserted-by": "crossref",
      "first-page": "1567",
      "issue": "8",
      "journal-title": "Cancer",
      "key": "9484_CR19",
      "unstructured": "Noruzinia M, Coupier I, Pujol P (2005) Is BRCA1/2-related breast carcinogenesis estrogen dependent? Cancer 104(8):1567–1574",
      "volume": "104",
      "year": "2005"
    },
    {
      "DOI": "10.1093/jnci/djn442",
      "author": "TR Rebbeck",
      "doi-asserted-by": "crossref",
      "first-page": "80",
      "issue": "2",
      "journal-title": "J Natl Cancer Inst",
      "key": "9484_CR20",
      "unstructured": "Rebbeck TR, Kauff ND, Domchek SM (2009) Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1/2 mutation carriers. J Natl Cancer Inst 101(2):80–87",
      "volume": "101",
      "year": "2009"
    },
    {
      "DOI": "10.1038/sj.onc.1210674",
      "author": "LP Jones",
      "doi-asserted-by": "crossref",
      "first-page": "794",
      "issue": "6",
      "journal-title": "Oncogene",
      "key": "9484_CR21",
      "unstructured": "Jones LP et al (2008) Activation of estrogen signaling pathways collaborates with loss of BRCA1 to promote development of ER alpha-negative and ER alpha-positive mammary preneoplasia and cancer. Oncogene 27(6):794–802",
      "volume": "27",
      "year": "2008"
    },
    {
      "DOI": "10.1093/jnci/dji372",
      "author": "B Fisher",
      "doi-asserted-by": "crossref",
      "first-page": "1652",
      "issue": "22",
      "journal-title": "J Natl Cancer Inst",
      "key": "9484_CR22",
      "unstructured": "Fisher B et al (2005) Tamoxifen for the prevention of breast cancer: current status of the national surgical adjuvant breast and bowel project P-1 study. J Natl Cancer Inst 97(22):1652–1662",
      "volume": "97",
      "year": "2005"
    },
    {
      "DOI": "10.1093/jnci/djk050",
      "author": "TJ Powles",
      "doi-asserted-by": "crossref",
      "first-page": "283",
      "issue": "4",
      "journal-title": "J Natl Cancer Inst",
      "key": "9484_CR23",
      "unstructured": "Powles TJ et al (2007) Twenty-year follow-up of the royal Marsden randomized, double-blinded tamoxifen breast cancer prevention trial. J Natl Cancer Inst 9(4):283–290",
      "volume": "9",
      "year": "2007"
    },
    {
      "DOI": "10.1001/jama.281.23.2189",
      "author": "SR Cummings",
      "doi-asserted-by": "crossref",
      "first-page": "2189",
      "issue": "23",
      "journal-title": "JAMA",
      "key": "9484_CR24",
      "unstructured": "Cummings SR et al (1999) The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple outcomes of raloxifene evaluation. JAMA 281(23):2189–2197",
      "volume": "281",
      "year": "1999"
    },
    {
      "DOI": "10.1158/1940-6207.CAPR-10-0076",
      "author": "VG Vogel",
      "doi-asserted-by": "crossref",
      "first-page": "696",
      "issue": "6",
      "journal-title": "Cancer Prev Res (Phila)",
      "key": "9484_CR25",
      "unstructured": "Vogel VG et al (2010) Update of the national surgical adjuvant breast and bowel project study of tamoxifen and raloxifene (STAR) P-2 trial: preventing breast cancer. Cancer Prev Res (Phila) 3(6):696–706",
      "volume": "3",
      "year": "2010"
    },
    {
      "DOI": "10.1093/jnci/djk049",
      "author": "J Cuzick",
      "doi-asserted-by": "crossref",
      "first-page": "272",
      "issue": "4",
      "journal-title": "J Natl Cancer Inst",
      "key": "9484_CR26",
      "unstructured": "Cuzick J et al (2007) Long-term results of tamoxifen prophylaxis for breast cancer: 96-month follow-up of the randomized IBIS-I trial. J Natl Cancer Inst 99(4):272–282",
      "volume": "99",
      "year": "2007"
    },
    {
      "DOI": "10.1038/nrc2048",
      "author": "VC Jordan",
      "doi-asserted-by": "crossref",
      "first-page": "46",
      "issue": "1",
      "journal-title": "Nat Rev Cancer",
      "key": "9484_CR27",
      "unstructured": "Jordan VC (2007) Chemoprevention of breast cancer with selective oestrogen-receptor modulators. Nat Rev Cancer 7(1):46–53",
      "volume": "7",
      "year": "2007"
    },
    {
      "DOI": "10.1093/jnci/djk154",
      "author": "U Veronesi",
      "doi-asserted-by": "crossref",
      "first-page": "727",
      "issue": "9",
      "journal-title": "J Natl Cancer Inst",
      "key": "9484_CR28",
      "unstructured": "Veronesi U et al (2007) Tamoxifen for the prevention of breast cancer: late results of the Italian randomized tamoxifen prevention trial among women with hysterectomy. J Natl Cancer Inst 99(9):727–737",
      "volume": "99",
      "year": "2007"
    },
    {
      "DOI": "10.1200/JCO.2009.27.8077",
      "author": "ME Ropka",
      "doi-asserted-by": "crossref",
      "first-page": "3090",
      "journal-title": "J Clin Oncol",
      "key": "9484_CR29",
      "unstructured": "Ropka ME, Keim J, Philbrick JT (2010) Patient decisions about breast cancer chemoprevention: a systematic review and meta-analysis. J Clin Oncol 28:3090–3095",
      "volume": "28",
      "year": "2010"
    },
    {
      "DOI": "10.1158/1055-9965.EPI-09-0930",
      "author": "WA Waters",
      "doi-asserted-by": "crossref",
      "first-page": "443",
      "journal-title": "Cancer Epidemiol Biomarkers Prev",
      "key": "9484_CR30",
      "unstructured": "Waters WA, Cronin KA, Graubard BI, Han PK, Freedman AN (2010) Prevalence of tamoxifen use for breast cancer chemoprevention among US women. Cancer Epidemiol Biomarkers Prev 19:443–446",
      "volume": "19",
      "year": "2010"
    },
    {
      "DOI": "10.1200/JCO.2009.23.1274",
      "author": "M Dowsett",
      "doi-asserted-by": "crossref",
      "first-page": "509",
      "issue": "3",
      "journal-title": "J Clin Oncol",
      "key": "9484_CR31",
      "unstructured": "Dowsett M et al (2010) Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen. J Clin Oncol 28(3):509–518",
      "volume": "28",
      "year": "2010"
    },
    {
      "DOI": "10.3816/CBC.2007.n.057",
      "author": "PE Goss",
      "doi-asserted-by": "crossref",
      "first-page": "895",
      "issue": "11",
      "journal-title": "Clin Breast Cancer",
      "key": "9484_CR32",
      "unstructured": "Goss PE et al (2007) National cancer institute of Canada clinical trials group MAP.3 trial: evaluation of exemestane to prevent breast cancer in postmenopausal women. Clin Breast Cancer 7(11):895–900",
      "volume": "7",
      "year": "2007"
    },
    {
      "DOI": "10.1586/14737140.8.9.1377",
      "author": "J Cuzick",
      "doi-asserted-by": "crossref",
      "first-page": "1377",
      "issue": "9",
      "journal-title": "Expert Rev Anticancer Ther",
      "key": "9484_CR33",
      "unstructured": "Cuzick J (2008) IBIS II: a breast cancer prevention trial in postmenopausal women using the aromatase inhibitor anastrozole. Expert Rev Anticancer Ther 8(9):1377–1385",
      "volume": "8",
      "year": "2008"
    },
    {
      "DOI": "10.1056/NEJMoa1103507",
      "author": "PE Goss",
      "doi-asserted-by": "crossref",
      "first-page": "2381",
      "issue": "25",
      "journal-title": "N Engl J Med",
      "key": "9484_CR34",
      "unstructured": "Goss PE, Ingle JN, Alés-Martínez JE, Cheung AM, Chlebowski RT, Wactawski-Wende J, McTiernan A, Robbins J, Johnson KC, Martin LW, Winquist E, Sarto GE, Garber JE, Fabian CJ, Pujol P, Maunsell E, Farmer P, Gelmon KA, Tu D, Richardson H, NCIC CTG MAP.3 Study Investigators (2011) Exemestane for breast-cancer prevention in postmenopausal women. N Engl J Med 364(25):2381–2391",
      "volume": "364",
      "year": "2011"
    },
    {
      "DOI": "10.1007/s10549-011-1655-3",
      "doi-asserted-by": "crossref",
      "key": "9484_CR35",
      "unstructured": "Lecarpentier J, Noguès C, Mouret-Fourme E, Stoppa-Lyonnet D, Lasset C, Caron O, Fricker JP, Gladieff L, Faivre L, Sobol H, Gesta P, Frenay M, Luporsi E, Coupier I (2011) Variation in breast cancer risk with mutation position, smoking, alcohol, and chest X-ray history, in the French national BRCA1/2 carrier cohort (GENEPSO). GENEPSO, Lidereau R, Andrieu N. Breast Cancer Res Treat. 2011 Jul 15 (epub ahead of print)"
    },
    {
      "DOI": "10.1016/S0140-6736(03)12342-2",
      "author": "J Cuzick",
      "doi-asserted-by": "crossref",
      "first-page": "296",
      "issue": "9354",
      "journal-title": "Lancet",
      "key": "9484_CR36",
      "unstructured": "Cuzick J et al (2003) Overview of the main outcomes in breast-cancer prevention trials. Lancet 361(9354):296–300",
      "volume": "361",
      "year": "2003"
    },
    {
      "DOI": "10.1016/S0140-6736(01)06039-1",
      "author": "D Evans",
      "doi-asserted-by": "crossref",
      "first-page": "889",
      "issue": "9285",
      "journal-title": "Lancet",
      "key": "9484_CR37",
      "unstructured": "Evans D et al (2001) Uptake of screening and prevention in women at very high risk of breast cancer. Lancet 358(9285):889–890",
      "volume": "358",
      "year": "2001"
    },
    {
      "DOI": "10.1136/jmg.2010.082768",
      "author": "DG Evans",
      "doi-asserted-by": "crossref",
      "first-page": "853",
      "issue": "12",
      "journal-title": "J Med Genet",
      "key": "9484_CR38",
      "unstructured": "Evans DG, Harvie M, Bundred N, Howell A (2010) Uptake of breast cancer prevention and screening trials. J Med Genet 47(12):853–855. Epub 2010 Oct 23",
      "volume": "47",
      "year": "2010"
    },
    {
      "DOI": "10.1200/JCO.2008.19.9430",
      "author": "MK Graeser",
      "doi-asserted-by": "crossref",
      "first-page": "5887",
      "issue": "35",
      "journal-title": "J Clin Oncol",
      "key": "9484_CR39",
      "unstructured": "Graeser MK et al (2009) Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers. J Clin Oncol 27(35):5887–5892",
      "volume": "27",
      "year": "2009"
    },
    {
      "DOI": "10.1016/j.jsbmb.2009.10.004",
      "author": "J Geisler",
      "doi-asserted-by": "crossref",
      "first-page": "294",
      "issue": "4–5",
      "journal-title": "J Steroid Biochem Mol Biol",
      "key": "9484_CR40",
      "unstructured": "Geisler J, Lonning PE (2010) Impact of aromatase inhibitors on bone health in breast cancer patients. J Steroid Biochem Mol Biol 118(4–5):294–299",
      "volume": "118",
      "year": "2010"
    },
    {
      "DOI": "10.1097/GCO.0b013e328334e44e",
      "author": "JE Mortimer",
      "doi-asserted-by": "crossref",
      "first-page": "56",
      "issue": "1",
      "journal-title": "Curr Opin Obstet Gynecol",
      "key": "9484_CR41",
      "unstructured": "Mortimer JE (2010) Managing the toxicities of the AI. Curr Opin Obstet Gynecol 22(1):56–60",
      "volume": "22",
      "year": "2010"
    }
  ],
  "reference-count": 41,
  "references-count": 41,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/s10689-011-9484-4"
    }
  },
  "score": 0,
  "short-container-title": [
    "Familial Cancer"
  ],
  "source": "Crossref",
  "title": [
    "Uptake of a randomized breast cancer prevention trial comparing letrozole to placebo in BRCA1/2 mutations carriers: the LIBER trial"
  ],
  "type": "journal-article",
  "volume": "11"
}